A sprawling U.S. mosquito-control system uses trucks, aircraft and larvicides across communities nationwide, fueling a nearly $2 billion domestic industry while prompting debate over pesticide exposure, environmental effects, insecticide resistance and whether routine spraying is being used too broadly.

By yourNEWS Media Newsroom

Mosquito-control programs responsible for protecting an estimated 600 million acres across the United States are increasingly confronting a difficult public-health tradeoff: how to prevent mosquito-borne disease without unnecessarily exposing people, wildlife and ecosystems to pesticides or accelerating the development of insecticide-resistant mosquitoes.

For decades, local governments and health departments have sprayed communities from trucks and aircraft as part of efforts to suppress mosquitoes capable of transmitting disease. The operations now form part of a global mosquito-control market estimated at $7.24 billion in 2026, with the U.S. market approaching $2 billion and industry projections pointing to continued market growth.

A 2026 Kline & Company survey estimates that 400 to 500 major mosquito or vector-control districts operate nationwide alongside approximately 1,000 to 2,000 smaller municipal and public-health programs. Together, those agencies are responsible for protecting roughly 600 million acres, although Kline estimates about 150 million acres are realistically available for chemical mosquito-control treatment because much of the broader territory lacks breeding habitat, favorable climate or significant human populations.

The 600 million-acre service footprint is equivalent to more than one-quarter of the nation’s total land area. The largest pesticide use occurs in the South, particularly Florida, Louisiana, Georgia, Texas and other humid Gulf Coast and Southeastern states where mosquito populations and disease concerns are persistent.

The commercial side of the system includes specialized mosquito-control manufacturers and major pesticide companies. Manufacturers supplying vector-control products include BASF and Syngenta as well as Envu, the former Bayer Environmental Science business acquired by private equity firm Cinven in 2022. Companies generally do not disclose revenue generated specifically by their mosquito-control lines.

Residents Question Repeated Neighborhood Treatments

For residents in heavily treated areas, mosquito control can be an unusually visible part of everyday life.

Florida Keys resident Heather Ray said she heard a helicopter flying low over her property before discovering that it was dropping small pesticide pellets intended to kill mosquito larvae. Ray said the material landed across her yard, deck and vehicles and on her daughter while the child was outside.

The Florida Keys Mosquito Control District routinely uses larvicides to attack immature mosquitoes before they emerge and also deploys trucks to apply products targeting adult mosquitoes when populations warrant treatment.

More than 700 miles away in Florida’s Okaloosa County, Jennifer O’Brien of The Defender reported seeing mosquito-control trucks pass through her neighborhood approximately once a week applying Kontrol 4-4, a formulation containing the widely used insecticide permethrin.

Permethrin remains registered for numerous uses in the United States and is the country’s most widely used mosquito adulticide, according to federal regulators. The chemical has a different regulatory status in Europe, where the European Union pesticide database lists permethrin as not approved as an active substance for plant-protection products.

Both women sought to keep pesticide applications away from their homes. Ray, who works with Children’s Health Defense and is a member of its Science Department, said she was told her property would be placed in a “no-fly zone,” but pellets continued to fall there.

O’Brien said she was initially told there was “no opt-out option,” although residents with chemical sensitivities could sign up for advance notice. After additional discussions with the local program, officials agreed to skip her property.

That offered only limited reassurance, she said, because “but it is in the air all around us.”

Similar concerns are emerging elsewhere. Carolyn McCuan, co-founder of the California advocacy organization Toxic-Free OC, said many residents do not realize broad-area mosquito spraying occurs in their communities until they encounter it directly. Once informed, she said, “the vast majority are opposed” and favor more targeted or nonchemical approaches.

Disease Prevention Remains the Public-Health Rationale

Mosquito-control agencies carry out the programs primarily to reduce the risk of vector-borne diseases, illnesses spread to people by mosquitoes, ticks and other organisms capable of carrying infectious pathogens.

The United States has approximately 200 mosquito species, but only a portion are significant vectors for human pathogens. Mosquito-transmitted viruses are among a larger group known as arboviruses, or arthropod-borne viruses.

In the Florida Keys, mosquito-control efforts focus heavily on species capable of spreading illnesses including yellow fever, Zika, chikungunya and dengue.

Elsewhere in the country, West Nile virus is a major focus and remains the most common mosquito-borne viral disease reported in the continental United States. Roughly 2,000 cases have been reported annually in recent years, although totals vary substantially from year to year.

Most people infected with West Nile do not develop symptoms. About one in five develop fever and other symptoms, while fewer than 1% develop serious neurological disease. Older adults and people with certain underlying medical conditions face greater risk of severe illness.

Public-health authorities therefore emphasize that pesticides can play an important role when surveillance shows disease-carrying mosquitoes are increasing. The dispute is less about whether mosquito control is ever justified than about how often broad chemical applications should occur and whether agencies consistently use surveillance, resistance testing and nonchemical alternatives before spraying.

Modern Programs Grew From the DDT Era

Large-scale chemical mosquito control became entrenched in the United States during the 1940s after researchers recognized DDT’s insecticidal power. The chemical became an important tool against mosquitoes and other insects until mounting concerns about environmental persistence and effects on human and environmental health led the United States to ban most DDT uses in the early 1970s.

Modern mosquito programs increasingly describe their strategy as integrated pest management, an approach combining surveillance, breeding-site removal, biological controls, larvicides, adulticides and resistance monitoring rather than depending on a single chemical.

Daniel Markowski, Ph.D., technical adviser to the American Mosquito Control Association, said pesticide use should be evaluated alongside both the threat posed by disease and the risks created by treatment.

“Good mosquito control involves balancing all of the various risks. The objective is not simply to minimize pesticide use regardless of circumstances, nor is it to spray routinely without justification,” Markowski said.

Mosquito-control operations remain highly decentralized. Most are run by cities, counties, health agencies and specialized districts responsible for vector control within local areas, producing large differences in funding, expertise, surveillance and treatment practices from one community to another.

That uneven capacity has been documented for years. A 2017 national assessment supported by the Centers for Disease Control and Prevention surveyed nearly 2,000 publicly funded mosquito-control programs and identified substantial gaps in staffing, expertise and technical capability.

Among the findings, 98% of surveyed programs lacked what the assessment considered basic pesticide-resistance testing or training capacity, while many treatment decisions were based heavily on historic practices or resident complaints rather than the surveillance-driven model envisioned by integrated mosquito management.

A 2020 follow-up survey found improvements in several areas of mosquito surveillance and control capacity, but a subsequent 2023 assessment reported another decline in local capacity.

Federal resources have also tended to rise after disease outbreaks and recede when the immediate threat diminishes. A review in the Journal of Medical Entomology warned that inconsistent funding, fragmented programs and growing insecticide resistance make sustained mosquito control more difficult.

Chemicals Vary Widely in Use and Risk

Mosquito programs generally divide pesticide use between products aimed at immature mosquitoes and products that kill adults.

Common larvicides include biological agents and insect growth regulators designed to prevent mosquito larvae from becoming biting adults. One widely used biological larvicide is Bacillus thuringiensis israelensis, or Bti, a bacterium that produces toxins lethal to certain insect larvae.

Other programs use Lysinibacillus sphaericus or methoprene.

Adult mosquitoes are frequently targeted with synthetic pyrethroids such as permethrin, resmethrin and sumithrin, as well as organophosphate insecticides including malathion and naled.

The U.S. Environmental Protection Agency says EPA-registered adulticides can be used for public-health mosquito control without posing risks of concern to the general population or environment when they are applied according to approved label directions. Ultra-low-volume spraying uses small amounts of active ingredient dispersed in very fine droplets designed to contact flying mosquitoes.

Critics argue that regulatory assessments of individual applications do not settle questions surrounding frequent community exposure or ecological effects, particularly where treatments are repeated through long mosquito seasons.

The possible susceptibility of children and pregnant women has long figured in debates about pesticide exposure because developing neurological, endocrine and immune systems can respond differently to toxic substances.

Organophosphate insecticides affect the nervous system and can cause acute poisoning at sufficiently high exposures. Pyrethroids generally have lower acute toxicity in humans, although exposure can cause skin, eye or respiratory irritation. Researchers have also examined possible longer-term endocrine and cancer associations, including an older study investigating pyrethroid-related compounds and breast cancer. Such observational findings do not by themselves establish that mosquito-control spraying causes cancer.

Environmental concerns can be more direct because some insecticides used against mosquitoes are toxic to aquatic organisms and pollinators.

A study examining aerial naled exposure and honey-bee survival illustrates longstanding concern about potential effects on pollinators. Naled is also toxic to some aquatic invertebrates, while pyrethroids are highly toxic to many fish and aquatic organisms.

Those hazards do not mean every properly conducted mosquito-control application produces ecological damage. Actual risk depends on the chemical, concentration, application method, environmental conditions and exposure.

Product labels nevertheless illustrate why application rules matter. Kontrol 4-4, for example, carries warnings that it is “extremely toxic” to aquatic organisms and “highly toxic” to bees exposed directly to treatment on blooming crops or weeds.

Pyrethroid-containing adulticides are among the products approved for mosquito control in the Florida Keys, where wetlands and aquatic habitats sit alongside heavily populated neighborhoods.

Broad insecticide applications can also affect insects that prey on mosquitoes, including dragonflies, potentially altering natural predator-prey relationships. The significance of those effects depends heavily on which pesticide is applied, at what dose and under what conditions.

Resistance Adds Pressure to Reduce Routine Spraying

Beyond Pesticides, an advocacy organization that favors reduced pesticide use, argues that broad adulticide programs are “of very limited efficacy” as a long-term control strategy because spraying adult mosquitoes does not eliminate eggs and breeding habitat, allowing populations to rebound.

The group favors surveillance, removal of standing water and other breeding sites, larval control and biological measures before adulticides are used.

One concern shared more broadly by federal authorities and mosquito-control professionals is insecticide resistance.

Mosquitoes reproduce rapidly, and repeated exposure to the same classes of insecticides can favor survivors carrying traits that make them less susceptible. Over generations, those traits can spread through a population until a product that once worked becomes less effective or fails altogether.

Research and surveillance have documented rising insecticide resistance in mosquito populations, creating a particular problem for local programs that do not routinely test whether the chemicals they are applying still kill the mosquito species being targeted.

A program that sprays without resistance data can therefore incur costs and expose people and ecosystems without achieving the intended reduction in mosquitoes.

The CDC’s current guidance emphasizes the opposite approach. Federal health officials say local agencies should use “integrated mosquito management”, combining disease and mosquito surveillance, breeding-site reduction, larval treatment, insecticide-resistance testing, adult mosquito control when warranted and continued evaluation of whether treatments actually work.

The CDC says properly applied adulticides can rapidly reduce adult mosquito populations and can be particularly valuable when mosquitoes are actively spreading disease. It does not recommend relying on adulticide spraying alone.

That distinction increasingly defines the mosquito-control debate.

Supporters of government programs point to diseases such as West Nile, dengue and eastern equine encephalitis as evidence that communities need the ability to act quickly when surveillance identifies a threat. Critics argue that routine calendar-based spraying or treatment driven primarily by nuisance complaints can expose large populations and ecosystems without demonstrating that disease risk justified the application.

Kline’s latest industry findings suggest some programs are moving toward greater use of larvicides, increased larval surveillance, product rotation and more precise application technology. Those strategies aim to stop mosquitoes earlier in their life cycle, limit repeated adulticide treatments and slow resistance.

For residents living underneath flight paths or along routes traveled by spray trucks, however, the debate is also about transparency and choice. Ray said pellets continued falling on her property despite assurances that it would be excluded, while O’Brien’s successful request to bypass her home did little to prevent exposure to treatments occurring throughout the surrounding neighborhood.

The expanding mosquito-control industry is therefore confronting two objectives that do not always fit neatly together: preventing outbreaks of potentially serious disease while limiting unnecessary pesticide use.

Federal guidance increasingly treats those goals as complementary rather than competing. Surveillance can identify when mosquitoes actually pose a threat, source reduction can eliminate breeding habitat, larvicides can prevent adults from emerging, resistance testing can prevent ineffective treatments and adulticides can be reserved for circumstances in which surveillance shows they are warranted.

As mosquito-control districts oversee hundreds of millions of acres and a U.S. market approaching $2 billion, the central question is becoming less about whether mosquitoes should be controlled and more about how precisely, transparently and selectively that control can be carried out.

Featured Image: yourNEWS Media Illustration

Original article